- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Marisa A. Sotomayor
News 18 results
In the News · Source: Global Legal Chronicle
August 7, 2025
K&S advises Oxford Biomedica PLC on its $125M secured loan facility provided by Oaktree Capital Management
Cases & Deals
August 1, 2025
King & Spalding advises Oxford Biomedica PLC on $125m secured financing package
Recognition
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
Recognition
June 5, 2025
King & Spalding Earns 209 Lawyer Rankings, 100 Practice Group Rankings in Chambers USA Guide
Recognition
April 21, 2025
Marine Money Recognizes King & Spalding for its Role Advising Abercrombie & Kent Travel Group on the “Innovation Deal of the Year”
Recognition
February 13, 2025
Chambers Global 2025 Recognizes King & Spalding as a Leading International Law Firm
Cases & Deals
August 23, 2024
King & Spalding Advises Abercrombie & Kent on $500 Million Financing
In the News · Source: Karryon,Travel Weekly, Seatrade Cruise News and The American Lawyer
In the News · Source: Debtwire
July 3, 2024
Marisa Sotomayor explains why what happens in the private credit market will largely depend on M&A activity
Recognition
June 6, 2024
King & Spalding Earns 198 Lawyer Rankings, 90 Practice Group Rankings in Chambers USA Guide
Recognition
March 18, 2024
Marisa Sotomayor Inducted Into American College of Commercial Finance Lawyers
Recognition
February 16, 2024
King & Spalding Earns Strong Rankings in Chambers Global 2024 Guide